CE mark Canary Molecular POC SARS-CoV-2 Test Nabs CE Mark The molecular point-of-care test uses biosensors and cloud-based analytics to deliver results within 20 minutes. NeoGenomics Blood-Based Minimal Residual Disease Test Receives CE Mark NeoGenomics subsidiary Inivata has also submitted the RaDaR test to the MolDx program in the US for reimbursement. Roche Gets CE Mark for Molecular SARS-CoV-2 Test With Saliva Samples The RT-PCR test can be used with nasal, nasopharyngeal, and oropharyngeal swab specimens, as well as saliva. Roche Infectious Disease Tests for New Molecular Instrument Nab CE Mark They are the first four assays launched for the Cobas 5800 platform, and Roche is pursuing CE marking for other tests, including the Cobas SARS-CoV-2 test. Genedrive Rapid Molecular COVID-19 Test Receives CE Mark The point-of-care test uses RT-LAMP technology and returns positive results in eight minutes and negative results in 17 minutes. Dec 3, 2021 Euformatics Gains CE-IVD Mark for OmnomicsNGS Dec 1, 2021 Eurofins Technologies Obtains CE Marks for SARS-CoV-2, Flu, RSV RT-PCR Kits Nov 24, 2021 NGeneBio Gets CE-IVD Mark for HLA Typing Assay Nov 18, 2021 New Roche Cobas System Nabs CE Mark Nov 10, 2021 BforCure Gets CE-IVD Mark for Molecular SARS-CoV-2 Test Kit Nov 8, 2021 German MDx Firm Mainz Biomed Raises $10M in IPO, Begins Trading on Nasdaq Nov 4, 2021 Genetron Gets CE Mark for Cancer Genomic Profiling Test Nov 3, 2021 Qiagen Gets CE Mark for Molecular Multiplex Respiratory Pathogen Assay Oct 27, 2021 GenomSys Gains CE Mark for New Genomic Analysis Software Oct 14, 2021 Biopix-T Gets CE Mark for Point-of-Care Platform, Molecular SARS-CoV-2 Test Oct 12, 2021 Genematrix HPV Detection Test Nabs CE Mark Oct 5, 2021 Takara Bio Gets CE-IVD Mark for SARS-CoV-2 Test Sep 29, 2021 Genedrive Receives CE Mark for Next-Generation Gene Amplification Platform Sep 23, 2021 LGC Receives CE Mark for AccuPlex SARS-CoV-2, Flu A/B, RSV Reference Material Kit Sep 23, 2021 Zymo Research Gets CE Mark for DNA Methylation Kit Sep 22, 2021 Roche Nabs CE Mark for Three Cobas Respiratory Test Panels Sep 20, 2021 DiaSorin Molecular Receives CE Mark for Multiplex COVID-19, Influenza Test Sep 16, 2021 Thermo Fisher Scientific Receives CE Mark for TaqPath COVID-19 RNase P 2.0 Testing Kit Sep 2, 2021 Biocartis H1 Revenues up 31 Percent Sep 1, 2021 Zymo Gets CE Mark for Saliva, Swab Sample Collection Kits Load More Breaking News Taiwanese Firm's IP Asserted in Suit Against Pacific Biosciences Found Partially Unpatentable In Ongoing False Advertising Suit, Judge Allows Natera Counterclaims Against Guardant Health Centogene Strikes Rare Disease Target Discovery Deal With Insilico Medicine Dilated Cardiomyopathy Gene Mutations Point to Possible Therapeutic Strategy Ginkgo Bioworks Acquires Massachusetts COVID-19 Testing Firm Mainz Biomed Taps DCN Dx to Aid European Study of Enhanced ColoAlert Assay The Scan Transplant Tests Edited Pig Kidneys The Associated Press reports a University of Alabama-Birmingham team transplanted genetically modified pig kidneys into a brain-dead human patient. UK Changes Some Gene-Edited Crop Rules A new law may enable gene-edited crops to be sold in the UK within about five years, New Scientist says. Pill Works Against Omicron in Lab Pfizer's antiviral pill to treat SARS-CoV-2 appears to work against the Omicron variant, the Wall Street Journal reports. Nature Papers Find Genetic Risk Factor for Smell, Taste Loss in COVID-19; Analyze TB Granulomas In Nature this week: genome-wide association study find locus linked to the risk COVID-19 patients losing their sense of taste or smell, and more.